Overview
Linlang Guo practices in Guangzhou, China. Guo is rated as a Distinguished expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Their top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Lymphofollicular Hyperplasia, and Cerebral Hypoxia.
Their clinical research consists of co-authoring 115 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 51 articles in the study of Small Cell Lung Cancer (SCLC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Small Cell Lung Cancer (SCLC)Guo isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Lung CancerGuo isAdvanced. Learn about Lung Cancer.
- Experienced
- Cerebral HypoxiaGuo isExperienced. Learn about Cerebral Hypoxia.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Endometrial CancerGuo isExperienced. Learn about Endometrial Cancer.
- Lung AdenocarcinomaGuo isExperienced. Learn about Lung Adenocarcinoma.
- Lymphofollicular Hyperplasia
- Nasopharyngeal CarcinomaGuo isExperienced. Learn about Nasopharyngeal Carcinoma.